298 related articles for article (PubMed ID: 29566713)
21. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
22. [PHF5A Promotes Proliferation and Migration of Non-Small Cell Lung Cancer
by Regulating of PI3K/AKT Pathway].
Wang H; Liu F; Bai C; Xu N
Zhongguo Fei Ai Za Zhi; 2023 Jan; 26(1):10-16. PubMed ID: 36792075
[TBL] [Abstract][Full Text] [Related]
23. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma.
Bai Y; Xiong L; Zhu M; Yang Z; Zhao J; Tang H
Cancer Biomark; 2019; 24(3):371-382. PubMed ID: 30883337
[TBL] [Abstract][Full Text] [Related]
24. VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer.
Lian L; Li XL; Xu MD; Li XM; Wu MY; Zhang Y; Tao M; Li W; Shen XM; Zhou C; Jiang M
BMC Cancer; 2019 Feb; 19(1):183. PubMed ID: 30819137
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
26. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
Wang X; Sun Q; Chen C; Yin R; Huang X; Wang X; Shi R; Xu L; Ren B
Oncotarget; 2016 Feb; 7(7):8029-42. PubMed ID: 26771237
[TBL] [Abstract][Full Text] [Related]
27. Reduced CENPU expression inhibits lung adenocarcinoma cell proliferation and migration through PI3K/AKT signaling.
Li J; Wang ZG; Pang LB; Zhang RH; Wang YY
Biosci Biotechnol Biochem; 2019 Jun; 83(6):1077-1084. PubMed ID: 30849291
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.
Zhang Y; Yuan Y; Liang P; Zhang Z; Guo X; Xia L; Zhao Y; Shu XS; Sun S; Ying Y; Cheng Y
Oncotarget; 2017 Jul; 8(28):45459-45469. PubMed ID: 28525372
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression.
Shi Y; Mao Z; Huang Y; Sun Y; Cao Q; Yin X; Huang J; Zhang Q
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32211805
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.
Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y
Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
[TBL] [Abstract][Full Text] [Related]
33. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
[TBL] [Abstract][Full Text] [Related]
34. C1QTNF6 as a novel biomarker regulates cellular behaviors in A549 cells and exacerbates the outcome of lung adenocarcinoma patients.
Han M; Wang B; Zhu M; Zhang Y
In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):614-621. PubMed ID: 31292940
[TBL] [Abstract][Full Text] [Related]
35. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of PTTG1 inhibits the growth and invasion of lung adenocarcinoma cells through regulation of TGFB1/SMAD3 signaling.
Li WH; Chang L; Xia YX; Wang L; Liu YY; Wang YH; Jiang Z; Xiao J; Wang ZR
Int J Immunopathol Pharmacol; 2015 Mar; 28(1):45-52. PubMed ID: 25816405
[TBL] [Abstract][Full Text] [Related]
37. DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle.
Cheng L; Yang Q; Li C; Dai L; Yang Y; Wang Q; Ding Y; Zhang J; Liu L; Zhang S; Fan P; Hu X; Xiang R; Yu D; Wei Y; Deng H
J Cell Mol Med; 2017 Aug; 21(8):1532-1544. PubMed ID: 28211159
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma.
Ding F; Wang D; Li XK; Yang L; Liu HY; Cui W; Liu ZH; Che YQ
Thorac Cancer; 2018 Jul; 9(7):827-835. PubMed ID: 29733545
[TBL] [Abstract][Full Text] [Related]
39. FOX-A1 contributes to acquisition of chemoresistance in human lung adenocarcinoma via transactivation of SOX5.
Chen D; Wang R; Yu C; Cao F; Zhang X; Yan F; Chen L; Zhu H; Yu Z; Feng J
EBioMedicine; 2019 Jun; 44():150-161. PubMed ID: 31147293
[TBL] [Abstract][Full Text] [Related]
40. High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma.
Li X; Liu M; Zhang Z; Zhang L; Liang X; Sun L; Zhong D
Thorac Cancer; 2019 May; 10(5):1103-1110. PubMed ID: 30907518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]